Welcome to LookChem.com Sign In|Join Free

CAS

  • or

121524-18-3

121524-18-3

Post Buying Request

121524-18-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

121524-18-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 121524-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,5,2 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 121524-18:
(8*1)+(7*2)+(6*1)+(5*5)+(4*2)+(3*4)+(2*1)+(1*8)=83
83 % 10 = 3
So 121524-18-3 is a valid CAS Registry Number.
InChI:InChI=1/C23H25N3O2/c27-17-14-19-10-4-6-15-25(19)22(28)13-12-20-21-11-5-7-16-26(21)24-23(20)18-8-2-1-3-9-18/h1-3,5,7-9,11-13,16,19,27H,4,6,10,14-15,17H2/b13-12+/t19-/m1/s1

121524-18-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-1-[(2R)-2-(2-hydroxyethyl)piperidin-1-yl]-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names 2-Piperidineethanol,1-(1-oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-2-propenyl)-,(R-(E))

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121524-18-3 SDS

121524-18-3Relevant articles and documents

Preventives and remedies for ischemic intestinal lesion and ileus

-

, (2008/06/13)

The present invention relates to a prophylactic and/or therapeutic composition for ischemic intestinal lesions and/or ileus which comprises as an active ingredient a pyrazolopyridine compound of the following formula: [wherein R1is lower alkyl group, etc; R2is a group of the formula: (wherein R4is protected amino group, etc; R5is hydrogen, etc); etc, and R3is hydrogen, etc] or a salt thereof.

Discovery of FK453, a novel non-xanthine adenosine A1 receptor antagonist

Akahane, Atsushi,Katayama, Hirohito,Mitsunaga, Takafumi,Kita, Yasuhiro,Kusunoki, Takahiro,Terai, Takao,Yoshida, Keizo,Shiokawa, Youichi

, p. 2059 - 2062 (2007/10/03)

Novel 2-phenylpyrazolo[1,5-a]pyridine-3-acryloylamides were synthesized and evaluated for diuretic activities. FK453 (1d), the most potent compound in this series, was found to be a potent and selective adenosine A1 receptor antagonist, whereas 1e, the (S)-enantiomer of FK453, was a weak and non-selective adenosine antagonist.

Pharmaceutical method of treatment using pyrazolopyridine compound

-

, (2008/06/13)

The invention relates to a method for the treatment of ailments which comprises administering an effective amount of the pyrazolopyridine compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121524-18-3